He is also the Co-Founder of Invictus Oncology, Cerulean Pharmaceuticals and Mitra Biotech. Shiladitya's research focuses on the development of novel nanomedicines for cancer and angiogenesis-based diseases. In 2005, he was recognized as one of the top 35 innovators worldwide by MIT Technology Review magazine. He has also received the Shakuntala Amir Chand Award from the Indian Council for Medical Research.